The Consultant role is integral to our business success and you will be working closely with the senior partners on a diverse range of pricing, strategic market access and training projects. The successful candidate will be enthusiastic, confident and have a flexible approach to work. You should be able to demonstrate excellent organisational skills including the ability to multi-task, prioritise work [...]
The Analyst role is integral to our business success and you will be working closely with the senior partners on a diverse range of strategic pricing and market access projects. The successful candidate will be enthusiastic, confident and have a flexible approach to work. You should be able to demonstrate excellent organisational skills including the ability to multi-task, prioritise work under [...]
Over the last 3 months, we have been conducting a survey to understand how pricing and market access is regarded within your company, and what your company is actively doing to enhance its market access capabilities. We are delighted to say that we have received a fabulous response, with 32 responses from at least 17 different companies. Given the variety in [...]
Remap Consulting are proud to announce that we are hosting two, 1 day market access training workshops for pharmaceutical professionals on 14th and 15th March 2018 in Downtown Boston, MA, USA. Day 1: The Fundamentals of Market Access; ideal for those where market access is not their core role but need to gain an understanding of market access to enable effective collaborations [...]
What impact does NICE’s modified Cancer Drugs Fund process mean for patient access to new oncology pharmaceuticals in England?
Remap Consulting recent analysis: “What impact does NICE's modified Cancer Drugs Fund process mean for patient access to new oncology pharmaceuticals in England?” was presented at ISPOR’s 20th Annual European Congress in Glasgow. In April 2016, NICE modified the Cancer Drugs Fund (CDF) appraisal process in England, to review all new oncology indications and publish final guidance within 90 days of marketing [...]
We are proud to be presenting our findings at ISPOR Glasgow on the impact of NICE's new CDF process for patient access to new oncology medicines. Join us at booth 205 to discuss our findings or call for a coffee and a chat
Paul Craddy is proud to be presenting 'Pricing and reimbursement considerations for Biosimilars' at the Global Pharmaceuitcal Regulatory Affairs Summit at the Clarion Congress Hotel in Prague tomorrow (24 Oct) Read our presentation here Biosimilar 2017 Prague 231017 1_0.
Graham Foxon, Managing Director of Remap Consulting will be presenting at the Northwest Biotech Initiative Event at the University of Liverpool, helping students to understand the art of consulting and how they can get involved.
ABPI have been denied the opportunity to legally challenge incorporation of the £20 million budget impact test being incorporated into NICE assessments. Read the full article here: https://goo.gl/hJKJ9B
The multi talented Remap Consulting Team, have been supporting the Macmillan coffee morning at the BioHub @ Alderley Park with their delicious home baking! Mary Berry eat your heart out :)